DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 41 filers reported holding DECIBEL THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $73,500 | +27.5% | 19,091 | 0.0% | 0.00% | – |
Q1 2023 | $57,655 | +65.0% | 19,091 | +12.0% | 0.00% | – |
Q4 2022 | $34,938 | -43.6% | 17,043 | -5.5% | 0.00% | – |
Q3 2022 | $62,000 | +3.3% | 18,043 | +26.7% | 0.00% | – |
Q2 2022 | $60,000 | +39.5% | 14,239 | 0.0% | 0.00% | – |
Q1 2022 | $43,000 | -35.8% | 14,239 | 0.0% | 0.00% | – |
Q4 2021 | $67,000 | -42.7% | 14,239 | -6.6% | 0.00% | – |
Q3 2021 | $117,000 | -10.7% | 15,239 | 0.0% | 0.00% | – |
Q2 2021 | $131,000 | -85.1% | 15,239 | -80.3% | 0.00% | – |
Q1 2021 | $879,000 | – | 77,392 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,139,685 | $27,001,000 | 4.71% |
Samsara BioCapital, LLC | 826,422 | $7,107,000 | 0.88% |
Orbimed Advisors | 4,945,192 | $42,529,000 | 0.43% |
Foresite Capital Management IV, LLC | 297,711 | $2,560,000 | 0.35% |
Alphabet Inc. | 1,636,258 | $14,072,000 | 0.29% |
Casdin Capital, LLC | 1,171,421 | $10,074,000 | 0.26% |
HARVARD MANAGEMENT CO INC | 328,798 | $2,828,000 | 0.16% |
Tibra Equities Europe Ltd | 43,400 | $373,000 | 0.12% |
AlphaCentric Advisors LLC | 45,000 | $387,000 | 0.10% |
Bronte Capital Management Pty Ltd. | 159,462 | $1,371,000 | 0.10% |